Weight Loss

When it comes to weight loss, it’s not just about diet and exercise. While lifestyle changes are essential, many people struggle with weight due to underlying medical factors, including hormonal imbalances, metabolic dysfunction, and insulin resistance. Addressing these factors is key to achieving sustainable weight loss.

At Evolution You, we take a holistic approach, combining lifestyle strategies with advanced medical interventions, including oral and injectable medications designed to support long-term weight management.

The Role of Weight Loss Medications

Weight loss medications can be an effective tool in the management of obesity, working through various mechanisms to suppress appetite, reduce fat absorption, regulate insulin, and enhance metabolism.

Oral Weight Loss Medications: How They Work

Oral weight loss medications offer different benefits depending on the individual’s needs:

🔹 Phentermine & Contrave – Appetite suppressants that help reduce hunger and cravings.

🔹 Orlistat – Prevents fat absorption in the digestive tract, reducing overall calorie intake.

🔹 Metformin – Primarily used for diabetes management, but can aid weight loss by improving insulin sensitivity and regulating blood sugar.

💡 On average, oral weight loss medications result in 5-10% total body weight loss over six months, depending on the individual’s metabolism and lifestyle choices.

The Latest in Weight Loss: Injectable Medications

The newest breakthrough treatments in medical weight loss are injectable medications, particularly GLP-1 receptor agonists and dual-action GLP-1/GIP receptor agonists.

GLP-1 Receptor Agonists: Wegovy & Ozempic

GLP-1 receptor agonists, like semaglutide (Wegovy, Ozempic), mimic the GLP-1 hormone, which regulates hunger, insulin levels, and digestion.

✅ Suppresses appetite and promotes satiety

✅ Slows gastric emptying, keeping you fuller for longer

✅ Improves insulin sensitivity, benefiting those with type 2 diabetes or insulin resistance

✅ Enhances blood sugar control and may reduce the risk of heart disease

🔹 Expected Results: Clinical studies show an average weight loss of 10-15% of total body weight over 6 to 12 months.

The Next Generation: Monjaro (Tirzepatide) / Zepbound

Monjaro (tirzepatide), also known as Zepbound, is a dual-action medication that targets both GLP-1 and GIP receptors, enhancing weight loss by working on multiple metabolic pathways.

🔹 How It Works:

✔️ Regulates appetite more effectively than GLP-1 medications alone

✔️ Enhances insulin sensitivity to support metabolic health

✔️ Increases energy expenditure, promoting faster fat loss

🔹 Expected Results: Clinical trials show an average weight loss of 15-22% of total body weight in just 6 months, with some individuals achieving even greater results.

💡 Why is Monjaro/Zepbound so effective? The dual-action effect on GLP-1 and GIP receptors provides a more powerful impact on hunger, insulin regulation, and metabolism than traditional GLP-1 medications.

Understanding the Side Effects of Weight Loss Medications

While these medications offer significant benefits, they can also come with side effects, especially in the early stages of treatment.

🔹 Oral Medications: Mild gastrointestinal symptoms such as nausea, constipation, or diarrhea, depending on the specific medication.

🔹 Injectable Medications: Nausea, vomiting, diarrhea, and stomach discomfort—these symptoms typically subside as the body adjusts to the medication.

An Approach to Long-Term Weight Loss

Weight loss medications can be powerful tools, but they work best when combined with a comprehensive lifestyle plan.

✅ Regular Physical Activity: Essential for maintaining metabolic health and long-term weight management.

✅ Mindful Eating & Stress Management: Emotional and environmental factors impact weight, making stress reduction strategies crucial.

✅ Quality Sleep: Poor sleep can disrupt hunger hormones and lead to weight gain.

✅ Protein Intake: Adequate protein is essential for muscle preservation, metabolic health, and long-term weight maintenance.